Effect of the combination of diltiazem and atenolol on exercise-induced regional myocardial ischemia in conscious dogs.
- 1 July 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 72 (1) , 233-243
- https://doi.org/10.1161/01.cir.72.1.233
Abstract
The effect of combination therapy with diltiazem and atenolol on the regional myocardial blood flow-function relationship was studied in eight conscious dogs with chronic coronary artery stenosis. An ameroid constrictor and hydraulic occluder were placed around the left circumflex coronary artery, sonomicrometers were implanted for measuring wall thickness in control and ischemic regions, and regional myocardial blood flow was measured with the microsphere method. Eighteen days (average) after surgery, resting regional myocardial function and blood flow were normal, but treadmill exercise induced severe regional myocardial dysfunction in the posterior wall (wall thickening during systole reduced from 25.5% to 2.7%, a 90% reduction). Subendocardial blood flow decreased by 68% from the control standing value, while subepicardial flow increased. An identical exercise bout was performed 3 hr after administration of atenolol (1.0 mg/kg orally) and 15 min after administration of diltiazem (0.3 mg/kg iv). Heart rate during running was significantly lower as were left ventricular peak systolic pressure, end-diastolic pressure, and peak dP/dt. Wall thickening in the control region was not augmented during exercise after atenolol and diltiazem. There was less dysfunction in the ischemic region (35% reduction) and the improved performance was accompanied by a substantial increase in subendocardial perfusion (0.31 +/- 0.14 vs 0.61 +/- 0.30 ml/min/g, a 36% reduction from rest). Epicardial flow was unchanged, and the endocardial/epicardial ratio increased (0.27 +/- 0.13 vs 0.62 +/- 0.29). Recovery time for regional wall thickening also improved. The beneficial effects of the combination of atenolol and diltiazem in a preparation of single-vessel chronic coronary stenosis were shown to be significantly greater than those of either drug alone.This publication has 21 references indexed in Scilit:
- Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: Report of a cooperative clinical trialThe American Journal of Cardiology, 1982
- The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effect.Circulation, 1982
- Ergonovine testing to detect spontaneous remissions of variant angina during long-term treatment with calcium antagonist drugsThe American Journal of Cardiology, 1981
- Improved exercise performance in persons with stable angina pectoris receiving diltiazemThe American Journal of Cardiology, 1981
- Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazemThe American Journal of Cardiology, 1980
- Nifedipine therapy for stable angina pectoris: Preliminary results of effects on angina frequency and treadmill exercise responseThe American Journal of Cardiology, 1979
- Exertional angina pectoris caused by coronary arterial spasm: Effects of various drugsThe American Journal of Cardiology, 1979
- MIC-II — A program for the determination of cardiac output, arterio-venous shunt and regional blood flow using the radioactive microsphere methodComputer Programs in Biomedicine, 1979
- Beneficial Effect of Diltiazem, a New Antianginal Drug, on Angina Pectoris at RestJapanese Heart Journal, 1979
- Improvement by propranolol of regional myocardial dysfunction and abnormal coronary flow pattern in conscious dogs with coronary narrowingThe American Journal of Cardiology, 1978